These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3830405)

  • 1. Ascorbic acid: a putative biochemical marker of irreversible neurologic functional loss following spinal cord injury.
    Pietronigro DD; DeCrescito V; Tomasula JJ; Demopoulos HB; Flamm ES
    Cent Nerv Syst Trauma; 1985; 2(2):85-92. PubMed ID: 3830405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of ascorbic acid from injured feline spinal cord.
    Pietronigro DD; Hovsepian M; Demopoulos HB; Flamm ES
    J Neurochem; 1983 Oct; 41(4):1072-6. PubMed ID: 6619847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury.
    Benzel EC; Hoffpauir GM; Thomas MM; Beal JA; Lancon JA; Kesterson L
    J Spinal Disord; 1990 Dec; 3(4):339-44. PubMed ID: 2134448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic hypothermia effectively reduces elevated extracellular ascorbate concentrations caused by acute spinal cord injury.
    Zhang Y; Lv Y; Ji W; Zhou R; Gao S; Zhou F
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):22-29. PubMed ID: 30526134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thyrotropin-releasing hormone on the neurologic impairment in rats with spinal cord injury: treatment starting 24 h and 7 days after injury.
    Hashimoto T; Fukuda N
    Eur J Pharmacol; 1991 Oct; 203(1):25-32. PubMed ID: 1797554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local metabolic changes in spinal cord injury.
    Can Med Assoc J; 1972 Oct; 107(7):597. PubMed ID: 4198528
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of lipid peroxidation in post-traumatic spinal cord degeneration: a review.
    Hall ED; Braughler JM
    Cent Nerv Syst Trauma; 1986; 3(4):281-94. PubMed ID: 3555850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental spinal cord injury induced an increase of extracellular ascorbic acid concentration in anesthetized rats: a microdialysis study.
    Tsai PJ; Chen WY; Tzeng SF; Liang WM; Yang CS
    Clin Chim Acta; 2005 Dec; 362(1-2):94-100. PubMed ID: 16033694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic effects of drugs in injured central nervous system.
    Pappius HM
    Cent Nerv Syst Trauma; 1985; 2(2):93-8. PubMed ID: 2869837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats.
    Pereira JE; Costa LM; Cabrita AM; Couto PA; Filipe VM; Magalhães LG; Fornaro M; Di Scipio F; Geuna S; Maurício AC; Varejão AS
    Exp Neurol; 2009 Nov; 220(1):71-81. PubMed ID: 19665461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone treatment of acute spinal cord injury: an introduction.
    Young W
    J Neurotrauma; 1991 Jul; 8 Suppl 1():S43-6. PubMed ID: 1920460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in tissue levels of ubiquinol-9 and -10, ascorbate and alpha-tocopherol following spinal cord impact trauma in rats.
    Lemke M; Frei B; Ames BN; Faden AI
    Neurosci Lett; 1990 Jan; 108(1-2):201-6. PubMed ID: 2304630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury.
    Demopoulos HB; Flamm ES; Seligman ML; Pietronigro DD; Tomasula J; DeCrescito V
    Can J Physiol Pharmacol; 1982 Nov; 60(11):1415-24. PubMed ID: 7151009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism.
    Braughler JM; Hall ED
    J Neurosurg; 1984 Aug; 61(2):290-5. PubMed ID: 6539814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular perfusion and metabolism in injured spinal cord after methylprednisolone treatment.
    Anderson DK; Means ED; Waters TR; Green ES
    J Neurosurg; 1982 Jan; 56(1):106-13. PubMed ID: 7054403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antifibrinolytic therapy in experimental spinal cord trauma.
    Brodner RA; Vangilder JC; Collins WF
    J Trauma; 1977 Jan; 17(1):48-54. PubMed ID: 833905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury.
    Kaptanoglu E; Tuncel M; Palaoglu S; Konan A; Demirpençe E; Kilinç K
    J Neurosurg; 2000 Jul; 93(1 Suppl):77-84. PubMed ID: 10879762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cord protection: development of a paraplegia-preventive solution.
    Ueno T; Furukawa K; Katayama Y; Suda H; Itoh T
    Ann Thorac Surg; 1994 Jul; 58(1):116-20. PubMed ID: 8037508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large intravenous dose of methylprednisolone.
    Braughler JM; Hall ED
    J Neurosurg; 1983 Aug; 59(2):256-61. PubMed ID: 6864292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.